Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2020

Monjuvi(Tafasitamab-Cxix)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$1.0M

Medicare cost, 2024

Medicare drug plans spent $1.0 million on Monjuvi (tafasitamab-cxix) in 2024, for 75 prescriptions and refills filled by 14 patients. It was first approved in 2020. At about $13,816 per prescription it is a high-cost drug.

Medicare cost, 2024

$1.0M

-8.2% from 2023

Prescriptions

75

$13,816.31 per claim

Patients

14

15 prescribers

Total spending, 2024

$1.0M

$74,015.95 per patient

Questions and answers

How much does Medicare spend on Monjuvi?

Medicare prescription drug plans paid $1.0M for Monjuvi in 2024, for 75 prescriptions and refills to 14 patients (down 8.2% from 2023). The average cost per claim was $13,816.31.

Which state spends the most on Monjuvi?

Pennsylvania had the highest Medicare cost for Monjuvi in 2024: $179K for 24 claims, followed by Arizona ($129K).

Who prescribes Monjuvi the most?

John D Sprandio Jr., hematology-oncology in Broomall, PA, had the highest Medicare cost for Monjuvi in 2024: 24 claims costing $179K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Monjuvi was $1.0M in 2024, after a high of $1.2M in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Monjuvi, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
John D Sprandio Jr. Broomall, PAHematology-Oncology24Under 11$179K
Timothy E Mathews Phoenix, AZNurse Practitioner12Under 11$67K
Donald W Northfelt Phoenix, AZHematology-Oncology11Under 11$62K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022420-$313K
2023166715$1.1M
2024157514$1.0M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Morphosys/Incyt75$1.0M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
2
RxNorm concept IDs
2387338, 2387343
Application numbers
BLA761163

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube